Treatment News : Muscle Loss, Fat Gain Associated With Increased Risk of Death - by Tim Horn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » March 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 2, 2011

Muscle Loss, Fat Gain Associated With Increased Risk of Death

by Tim Horn

HIV-positive individuals experiencing a loss of muscle mass and an increase in abdominal fat may face an increased risk of death, according to new data from the Fat Redistribution and Metabolic Change in HIV Infection (FRAM) study presented Tuesday, March 1, at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) in Boston.

Muscle loss, a hallmark symptom of wasting syndrome, is still a concern for many people living with HIV. Whether it occurs as a result of disease or aging, muscle loss can negatively affect survival if it is bad enough. This observation prompted Rebecca Scherzer, MD, and her colleagues to pose the following question: Does decreased muscle mass, lipoatrophy and/or gains in abdominal fat predict five-year mortality in a cohort of HIV-positive individuals?

To answer this question, Scherzer turned to the FRAM, which enrolled 1,183 HIV-positive men and women between 2000 and 2002. During the initial examinations of these volunteers, whole-body MRI was used to measure regional and total muscle and fat tissue. Five years later, 794 patients were known to be alive, 128 were known to be dead and the statuses of 261 were unknown.

Using these data, Scherzer’s group looked for associations between muscle/fat measurements—divided into three groups, or tertiles, with the worse muscle measurements in lowest tertile and the worst fat measurements in the highest tertile—and death rates (from any cause) over five years of follow-up. 

Deaths from any cause were more likely to occur among those in the lowest muscle measurement tertiles compared with those in the higher tertiles. For example, HIV-positive participants with arm muscle in the lowest tertile had a five-year death rate of 23 percent, compared with 11 percent and 8 percent of those in the middle and highest tertiles, respectively.

After adjusting the data for factors that can potentially skew the results—such as demographics, cardiovascular risk factors, HIV-related factors, inflammatory markers and kidney disease—Scherzer’s group found that lower arm muscle, lower leg muscle and higher amounts of deep belly fat were each associated with an increased risk of death during the five-year follow-up period.

Those in the lowest arm or leg muscle measurement tertiles were twice as likely to die, compared with those in the highest arm and leg muscle measurement tertiles. Similarly, those in the highest tertile of abdominal fat measurements were more than twice as likely to die, compared with those in the lowest fat measurement tertile.

Lipoatrophy—fat loss in the arms or legs—did not appear to be associated with an increased risk of death.

Discussing the clinical implications of these findings, Scherzer noted that Body Mass Index (BMI) measurements—a basic calculation of body fat using a person’s weight and height—may not accurately predict health risks in HIV-positive patients, given that the number will remain constant as muscle mass decreases and fat mass increases. “In turn,” she noted, “clinicians should consider measuring waist circumference and mid-arm muscle circumference in HIV-positive patients, and should be aware that patients with excess central fat may not necessarily have low enough BMI to alert them to their true level of risk.”

Search: FRAM, lipoatrophy, muscle loss, wasting, lipohypertrophy, abdominal fat, adiposity, obesity, mortality


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (3 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    andais
    Red House
    West Virginia


    soy_Ric
    Rochester
    New York


    Sexynyrican
    Brooklyn
    New York


    kmfdm221
    Arcata
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Can social media help stop HIV stigma?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.